SiliconWadi

Ilya Ryabinin · Silicon Wadi

Biotech investing.
AI leadership.
Company building.

Silicon Wadi is led by Ilya Ryabinin, an investor, board director, and AI leader.

Our work connects biotech investment research with the companies and technology we build. BioDosier is at the centre of that work.

Ilya Ryabinin, founder of Silicon Wadi
Ilya RyabininFounder, Silicon Wadi

BioDosier

The science, the business,
and the investment thesis.

Biotech investing means understanding both clinical evidence and commercial reality. BioDosier brings that research together: the trials, the company’s finances, and the events that could change the thesis.

AI supports the research. Investment judgment stays with the investor.

Visit BioDosier (opens in a new tab)

Private research desk · Access for approved accounts

Inside the researchBioDosier

Assess the clinical evidence

What do the results
actually tell us?

  • Does the effect matter for patients?
  • How does it compare with the standard of care?
  • What does the safety profile change?

Trial design / Clinical results / Safety data

Also taking shape

Dementia CoPilot

In development

Support for everyday life.
Directed by the person living it.

We’re developing a personal companion to help people living with dementia maintain independence. Support for memory, daily routines, and staying connected starts with the individual’s choices.

Discover Dementia CoPilot (opens in a new tab)

Operating & board roles

AI leadership.
Strategic focus.

Alongside our ventures, Ilya’s work spans AI leadership and startup board roles.

Building AI-first companies

We work with leadership teams to rethink how a company reaches its market, runs its operations, and makes decisions. AI adoption needs to serve the business across go-to-market, internal workflows, and governance.

Keeping the company on course

Our board work brings an independent perspective to priorities, resources, and execution. We help leadership assess new opportunities while staying focused on the company’s core objectives.

Get in touch

Continue the conversation.

For introductions, our ventures, or a shared investment interest.